The information contained on this web page is only a summary of information presented in more detail in the Notice of (I) Pendency of Class Action and Proposed Settlement; (II) Settlement Hearing; and (III) Motion for Attorneys’ Fees and Litigation Expenses (the “Notice”), which you can access by clicking here.  Since this website is just a summary, you should review the Notice for additional details. 

The Parties have settled the Action for $18,250,000 in cash (the “Settlement”) for the benefit of the Settlement Class.

On April 13, 2022, the Court held a hearing to consider final approval of the Settlement and related matters.  Following the hearing, the Court entered a final Judgment approving the Settlement, an Order approving the Plan of Allocation for the proceeds of the Settlement, and an Order awarding attorney's fees and litigation expenses.

The Settlement Class consists of: 

all persons who purchased Merit common stock from February 26, 2019 through October 30, 2019, inclusive (the “Class Period”), and who were damaged thereby.
  

Excluded from the Settlement Class are certain persons and entities (see paragraph 25 of the Notice) or those who requested exclusion pursuant to the instructions set forth in the Notice.

Please read the Notice to fully understand your rights and options. Copies of the Notice can be found in the menu on the left of this page.

The claims administration concluded in November 2022. We filed the distribution motion on November 29, 2022. On January 5, 2023 the Court entered the Order Approving the Distribution Plan. The initial distribution occurred on February 10, 2023. The second distribution occurred in July 2024. Subsequent distributions will occur on a rolling basis provided that net settlement funds are available.

If you have questions, you may call the Merit Medical Securities Litigation Help Line at 1-877-242-2522 or email info@MeritMedicalSecuritiesLitigation.com.